Psychedelic Stock Review

In a press release issued on February 15, Psycheceutical Bioscience (BWVI), in partnership with iNGENū, a contract research organization in the cannabinoid and psychedelic...

Must Watch Video. Topical Application to Improve Delivery of FDA-Approved Drugs. https://youtu.be/2CGT7P9QEvo Can this be used for Ketamine treatments? Time will tell, as they are...

A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of applying NeuroDirect™ ketamine topical...

Look What We Found! We launched the Psychedelic Stock Review a little more than a year ago and decided to take a wait-and-see attitude. We...

Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests NeuroDirect™ Ketamine....

A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen? PharmaVoice Psycheceutical is developing a back-of-the-neck topical treatment for ketamine but believes the delivery...

Steve Cohen from Point 72, Acquires 18,950,000 Shares of Cybin. Here's the filing, end of transmission. As we have nothing else to add. AKA...

“The only legitimate addiction interrupter capable of breaking a heroin, meth, opiate, or alcohol addiction in a single 12-hour session.” Known as the “Psychedelic Concierge...

Amazing New Technologies Keep Popping up. We love when this happens during Sector Bear Markets, which Psychedelics have clearly been in. Amazing technology can be...

RELATED: Matthew Perry Reveals he Spent About $9M Trying to get Sober. Psychedelics CURED My Alcoholism—News Anchor Jon Kostakopoulos / Apollo Pact CEO https://youtu.be/ghqY7s6UweU?si=-a2tuAGflKfLKI_j https://youtu.be/fZzJB_UJ1X8?si=CsjSUacJ1qItKVyN Participant On Life-Changing Sobriety...